Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Percutaneous Radiofrequency Ablation versus Surgical Resection for the Treatment of Small Hepatic Carcinoma: A Meta-analysis
2016
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Percutaneous Angioplasty Using a Paclitaxel-Coated Balloon Improves Target Lesion Restenosis on Inflow Lesions of Autogenous Radiocephalic Fistulas: A Pilot Study
2014
Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B
2006
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Hepatocellular carcinoma
2003 Standout
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
2014
Natural history of hepatitis B
2003
Length polymorphisms of heme oxygenase-1 determine the effect of far-infrared therapy on the function of arteriovenous fistula in hemodialysis patients: a novel physicogenomic study
2013
Primary liver cancer: Worldwide incidence and trends
2004 Standout
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Surveillance for Hepatocellular Carcinoma and Early Diagnosis
2007
Hepatocellular carcinoma
2018 Standout
Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog
2012
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
Management of patients with hepatitis B who require immunosuppressive therapy
2013
Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)
2016
Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy to Treat Morbid Obesity-Related Comorbidities: a Systematic Review and Meta-analysis
2015
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection
2003
Delayed HBV reactivation in rituximab-containing chemotherapy: How long should we continue anti-virus prophylaxis or monitoring HBV-DNA?
2016
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection
2002
Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus
2008
HBsAg seroclearance in asymptomatic carriers of high endemic areas
2007
Hepatocellular carcinoma
2012 Standout
Prognosis prediction and staging
2014
“Venopathy” at work: recasting neointimal hyperplasia in a new light
2010
Poor Recognition of Risk Factors for Hepatitis B by Physicians Prescribing Immunosuppressive Therapy: A Call for Universal Rather than Risk-Based Screening
2015
Hepatitis B virus infection
2009 Standout
Hepatocellular carcinoma
2021 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Chronic hepatitis B
2001
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
2014
Natural History of Chronic Hepatitis B Virus Infection: What We Knew in 1981 and What We Know in 2005
2006
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
2004 Standout
Hepatitis B vaccines
2003
Cancer-Specific Mortality in Chronic Kidney Disease
2011
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Validation of the HCC‐MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy
2008
Management of Hepatocellular Carcinoma *
2005 Standout
Diabetes in Asia
2009 Standout
A novel and validated prognostic index in hepatocellular carcinoma: The inflammation based index (IBI)
2012
Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method – Analysis of 2010 Taiwanese patients
2009
HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects
2004
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Post-angioplasty Far Infrared Radiation Therapy Improves 1-Year Angioplasty-Free Hemodialysis Access Patency of Recurrent Obstructive Lesions
2013
Lack of evidence of viral reactivation in HBsAg-negative HBcAb-positive and HCV patients undergoing immunosuppressive therapy for psoriasis
2014
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
2006 Standout
Chronic hepatitis B
2007 Standout
Chronic hepatitis C and superimposed nonalcoholic fatty liver disease
2001
Chronic hepatitis B: Update 2009 #
2009 Standout
Role of viral factors in the natural course and therapy of chronic hepatitis B
2007
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
2012 Standout
Lymphoproliferative Disease and Hepatitis B Reactivation: Challenges in the Era of Rapidly Evolving Targeted Therapy
2015
Occult hepatitis B virus infection
2006
Severe muscle depletion in patients on the liver transplant wait list: Its prevalence and independent prognostic value
2012
Treatment of intermediate-stage hepatocellular carcinoma
2014
Genomic Analysis Reveals a Potential Role for Cell Cycle Perturbation in HCV-Mediated Apoptosis of Cultured Hepatocytes
2009 StandoutNobel
Local-Regional Treatment of Hepatocellular Carcinoma
2011
Reporting performance of prognostic models in cancer: a review
2010
Persistent Hepatitis B Virus Infection in Subjects Without Hepatitis B Surface Antigen: Clinically Significant or Purely “Occult”?
2001
Prevention of Hepatitis B reactivation in the setting of immunosuppression
2016
Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment
2016
Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance
2004
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study
2016
Reactivation of hepatitis B virus during targeted therapies for cancer and immune-mediated disorders
2016
Hepatocellular Carcinoma
2011 Standout
Treatment of Hepatocellular Carcinoma
2016
Prevention of hepatitis B virus–related hepatocellular carcinoma
2004
Level of α-Fetoprotein Predicts Mortality Among Patients With Hepatitis C–Related Hepatocellular Carcinoma
2011
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017
Chronic Kidney Disease
2016 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma
2013
Hepatocellular carcinoma
2022 Standout
HBsAg Seroclearance in Chronic Hepatitis B in Asian Patients: Replicative Level and Risk of Hepatocellular Carcinoma
2008
Effect of Far Infrared Therapy on Arteriovenous Fistula Maturation: An Open-Label Randomized Controlled Trial
2013
Hospice Offers More Palliative Care but Costs Less Than Usual Care for Terminal Geriatric Hepatocellular Carcinoma Patients: A Nationwide Study
2013
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus
2001
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
2019
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity
2018 Standout
Hepatitis B reactivation in HBsAg‐negative/HBcAb‐positive patients receiving rituximab for lymphoma: a meta‐analysis
2015
Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences.
2002
Entecavir vs Lamivudine for Prevention of Hepatitis B Virus Reactivation Among Patients With Untreated Diffuse Large B-Cell Lymphoma Receiving R-CHOP Chemotherapy
2014
Comparison of Percutaneous Acetic Acid Injection and Percutaneous Ethanol Injection for Hepatocellular Carcinoma in Cirrhotic Patients: A Prospective Study
2003
Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune‐suppressing and anticancer drugs: Just the tip of the iceberg?
2014
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta‐analysis
2017
Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus–infected patients treated with direct‐acting antivirals
2017
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
An adipocentric view of liver fibrosis and cirrhosis.
2004
Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study
2014
Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis‐4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: A systemic review and meta‐analysis
2014
Meta-analysis of prophylactic entecavir or lamivudine against hepatitis B virus reactivation.
2017
Works of Pui-Ching Lee being referenced
Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection
2003
Fever and Infectious Complications After Percutaneous Acetic Acid Injection Therapy for Hepatocellular Carcinoma: Incidence and Risk Factor Analysis
2006
Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Renal Insufficiency
2010
Differential Mechanism and Prognostic Impact of Diabetes Mellitus on Patients with Hepatocellular Carcinoma Undergoing Surgical and Nonsurgical Treatment
2004
Selecting a Short-term Prognostic Model for Hepatocellular Carcinoma
2009
The Sequential Changes of the Model for End-stage Liver Disease Score Correlate With the Severity of Liver Cirrhosis in Patients With Hepatocellular Carcinoma Undergoing Locoregional Therapy
2006
Evaluation of the increase in model for end-stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child–Turcotte–Pugh score
2005
Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy
2004
Variable Pump Flow–Based Doppler Ultrasound Method
2004
Survival Benefit of Cirrhotic Patients with Hepatocellular Carcinoma Treated by Percutaneous Ethanol Injection as a Salvage Therapy
2002
Different Model for End-Stage Liver Disease Score Block Distributions May Have a Variable Ability for Outcome Prediction
2005
Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis
1998
Proposal of a Modified Cancer of the Liver Italian Program Staging System Based on the Model for End-Stage Liver Disease for Patients with Hepatocellular Carcinoma Undergoing Loco-Regional Therapy
2006
Differential Influences of Gastric Bypass and Sleeve Gastrectomy on Plasma Nesfatin-1 and Obestatin Levels in Patients with Type 2 Diabetes Mellitus
2013
Fatal Reactivation of Hepatitis B Virus in a Patient Who Was Hepatitis B Surface Antigen Negative and Core Antibody Positive Before Receiving Chemotherapy for Non-Hodgkin Lymphoma
2009
Far-Infrared Therapy
2007
A new prognostic model for hepatocellular carcinoma based on total tumor volume: The Taipei Integrated Scoring system
2010
Diabetes Mellitus as a Risk Factor of Liver Cirrhosis in Patients With Chronic Hepatitis B Virus Infection
2000
The Model for End-Stage Liver Disease Based Cancer Staging Systems Are Better Prognostic Models for Hepatocellular Carcinoma: A Prospective Sequential Survey
2007
Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B
2013
Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma
2010